This information was published on 2025-01-13T00:15:23 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2491013 (IR 1816631) |
| (220) |
12 Aug 2024
|
| (511) (510) |
Class 5
Pharmaceutical preparations to treat inflammatory diseases and disorders, and diseases and disorders of the immune system, dermatomyositis, systemic lupus erythematosus (SLE), hidradenitis suppurativa, scleroderma, sarcoidosis, juvenile dermatomyositis, non-infectious uveitis, and Crohn's Disease. |
| (540) | ALISITY |
| (550) | Word |
| (730) |
PRIOVANT THERAPEUTICS, INC.
|
Find out more about publications on the About page.